Annual EBITDA
-$80.61M$32.02M-65.88%
Summary
- Current Value
- As of today, ZVRA annual EBITDA is -$80.61M, down -65.88% on
- Historical Performance
- ZVRA annual EBITDA is down -1109.44% over the past 3 years, and down -302.41% over the past 5 years
- All-Time High Comparison
- ZVRA annual EBITDA is currently -1109.44% below its historical high of $7.99M set on
- 3-Year Low Comparison
- ZVRA annual EBITDA is at its 3-year low
- Sector Comparison
- ZVRA annual EBITDA is higher than 20.44% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$80.61M | -65.9% | -1109.4% | -302.4% | -1555.6% | |
| Quarterly EBITDA | $4.54M | +117.7% | +172.8% | +495.7% | +352.6% | |
| TTM EBITDA | -$23.62M | +70.7% | -33.3% | -262.2% | -1216.1% | |
| Price | $8.48 | +2.9% | +85.6% | +2.8% | – | |
| PE Ratio | 13.44 | – | – | – | – | |
| Annual Revenue | $23.61M | -14.0% | -17.6% | +83.9% | +100.0% | |
| Annual EPS | -$2.28 | -75.6% | -7.9% | +82.8% | -2625.6% | |
| -$87.00M | -75.4% | -1225.7% | -327.8% | -1530.2% | ||
| Annual Net Income | -$105.51M | -129.1% | -1133.3% | -330.3% | -10000.0% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$23.96M | N/A | -236.5% |
| 5Y | $7.99M | -1109.4% | |
| All | $7.99M | -1109.4% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$80.61M | at low | |
| 5Y | -$80.61M | at low | |
| All | -$80.61M | at low |
EBITDA History
FAQ
What is the current annual EBITDA of ZVRA?
As of today, ZVRA annual EBITDA is -$80.61M
What is 1-year change in ZVRA annual EBITDA?
ZVRA annual EBITDA is down -65.88% year-over-year
What is 3-year change in ZVRA annual EBITDA?
ZVRA annual EBITDA is down -1109.44% over the past 3 years
How far is ZVRA annual EBITDA from its all-time high?
ZVRA annual EBITDA is currently -1109.44% below its historical high of $7.99M set on December 31, 2021
How does ZVRA annual EBITDA rank versus sector peers?
ZVRA annual EBITDA is higher than 20.44% of companies in Healthcare sector
When is ZVRA next annual earnings release?
The next annual earnings release for ZVRA is on
Quarterly EBITDA
$4.54M$15.21M+142.47%
Summary
- Current Value
- As of today, ZVRA quarterly EBITDA is $4.54M, up +142.47% on
- Historical Performance
- ZVRA quarterly EBITDA is up +117.65% year-over-year, and up +172.82% over the past 3 years
- All-Time High Comparison
- ZVRA quarterly EBITDA is currently -35.44% below its historical high of $7.02M set on
- 3-Year Low Comparison
- ZVRA quarterly EBITDA is +117.65% above its 3-year low of -$25.69M reached on
- Sector Comparison
- ZVRA quarterly EBITDA is higher than 76.24% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $4.54M | +142.5% | +117.7% | +172.8% | +495.7% | |
| Annual EBITDA | -$80.61M | – | -65.9% | -1109.4% | -302.4% | |
| TTM EBITDA | -$23.62M | +56.1% | +70.7% | -33.3% | -262.2% | |
| Price | $8.48 | -16.8% | +2.9% | +85.6% | +2.8% | |
| PE Ratio | 13.44 | -16.8% | – | – | – | |
| Quarterly Revenue | $26.06M | +0.7% | +605.4% | +806.9% | +1253.9% | |
| Quarterly EPS | -$0.01 | -100.7% | +98.6% | +94.9% | +98.6% | |
| $4.14M | +133.6% | +115.2% | +162.5% | +441.6% | ||
| Quarterly Net Income | -$544.00K | -100.7% | +98.4% | +91.8% | +81.9% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $4.54M | at high | |
| 3Y | $4.54M | at high | |
| 5Y | $7.02M | -35.4% | |
| All | $7.02M | -35.4% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$13.77M | N/A | +132.9% |
| 3Y | -$25.69M | +117.7% | |
| 5Y | -$25.69M | +117.7% | |
| All | -$25.69M | +117.7% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of ZVRA?
As of today, ZVRA quarterly EBITDA is $4.54M
What is ZVRA quarterly EBITDA most recent change?
ZVRA quarterly EBITDA was up +142.47% on September 30, 2025
What is 1-year change in ZVRA quarterly EBITDA?
ZVRA quarterly EBITDA is up +117.65% year-over-year
How far is ZVRA quarterly EBITDA from its all-time high?
ZVRA quarterly EBITDA is currently -35.44% below its historical high of $7.02M set on March 1, 2021
How does ZVRA quarterly EBITDA rank versus sector peers?
ZVRA quarterly EBITDA is higher than 76.24% of companies in Healthcare sector
When is ZVRA next earnings release?
The next earnings release for ZVRA is on
TTM EBITDA
-$23.62M$30.22M+56.13%
Summary
- Current Value
- As of today, ZVRA TTM EBITDA is -$23.62M, up +56.13% on
- Historical Performance
- ZVRA TTM EBITDA is up +70.74% year-over-year, and down -33.30% over the past 3 years
- All-Time High Comparison
- ZVRA TTM EBITDA is currently -373.90% below its historical high of $8.63M set on
- 3-Year Low Comparison
- ZVRA TTM EBITDA is +70.74% above its 3-year low of -$80.73M reached on
- Sector Comparison
- ZVRA TTM EBITDA is higher than 43.18% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$23.62M | +56.1% | +70.7% | -33.3% | -262.2% | |
| Annual EBITDA | -$80.61M | – | -65.9% | -1109.4% | -302.4% | |
| Quarterly EBITDA | $4.54M | +142.5% | +117.7% | +172.8% | +495.7% | |
| Price | $8.48 | -16.8% | +2.9% | +85.6% | +2.8% | |
| PE Ratio | 13.44 | -16.8% | – | – | – | |
| TTM Revenue | $84.39M | +36.1% | +240.5% | +687.1% | +586.2% | |
| TTM EPS | $0.63 | +1257.4% | +132.1% | +161.8% | +112.0% | |
| -$28.96M | +52.1% | +66.4% | -57.1% | -325.6% | ||
| TTM Net Income | $35.33M | +1236.0% | +141.6% | +200.3% | +353.4% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$23.62M | at high | |
| 3Y | -$23.62M | at high | |
| 5Y | $8.63M | -373.9% | |
| All | $8.63M | -373.9% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$80.61M | N/A | +70.7% |
| 3Y | -$80.73M | +70.7% | |
| 5Y | -$80.73M | +70.7% | |
| All | -$80.73M | +70.7% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of ZVRA?
As of today, ZVRA TTM EBITDA is -$23.62M
What is ZVRA TTM EBITDA most recent change?
ZVRA TTM EBITDA was up +56.13% on September 30, 2025
What is 1-year change in ZVRA TTM EBITDA?
ZVRA TTM EBITDA is up +70.74% year-over-year
How far is ZVRA TTM EBITDA from its all-time high?
ZVRA TTM EBITDA is currently -373.90% below its historical high of $8.63M set on June 1, 2021
How does ZVRA TTM EBITDA rank versus sector peers?
ZVRA TTM EBITDA is higher than 43.18% of companies in Healthcare sector
When is ZVRA next earnings release?
The next earnings release for ZVRA is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- ZVRA Official Website zevra.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1434647/000143464725000011/0001434647-25-000011-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1434647/000143774925007320/0001437749-25-007320-index.htm
- ZVRA Profile on Yahoo Finance finance.yahoo.com/quote/ZVRA
- ZVRA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/zvra